Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceCARBOMEDICS CARBO-SEAL VALSALVA ASCENDING AORTIC PROSTHESIS
Generic NameHEART-VALVE, MECHANICAL
ApplicantCORCYM S.r.l.
Via Crescentino, sn
Saluggia 13040
PMA NumberP900060
Supplement NumberS024
Date Received06/11/2002
Decision Date12/10/2002
Product Code LWQ 
Advisory Committee Cardiovascular
Supplement TypeNormal 180 Day Track
Supplement Reason Change Design/Components/Specifications/Material
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
APPROVAL TO COMBINE THE CARBOMEDICS PROSTHETIC HEART VALVE (CPHV; APPROVED ON SEPTEMBER 29, 1993 UNDER P900060) WITH THE SULZER VASCUTEK GELWEAVE VALSALVA VASCULAR PROSTHESIS (CLEARED ON JUNE 13, 2002 UNDER K013022). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME CARBOMEDICS CARBO-SEAL VALSALVA ASCENDING AORTIC PROSTHESIS, MODEL CP-(SIZE), WILL BE AVAILABLE IN SIZES 21, 23, 25, 27, 29, 31, AND 33 MM, AND IS INDICATED FOR USE IN OPEN HEART SURGERY FOR SIMULTANEOUS REPLACEMENT OF THE ASCENDING AORTA AND THE AORTIC VALVE IN CASES OF ANEURYSM, DISSECTION, OR OTHER DISEASE CONDITIONS OF THE AORTA COMBINED WITH DISEASE OR DEGENERATION OF THE AORTIC VALVE.
-
-